BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Half of Global Workforce in India, Mylan Inc. Tells DIPP

  August 14, 2013

   · 

  1 min read
• Pharm Country

  BrainStorm Cell Therapeutics Inc. Will Host a Conference Call to Update Shareholders on Recent Company Developments

  August 14, 2013

   · 

  1 min read
• Policy

  C.R. Bard Put Profits Ahead of Patients’ Safety, Lawyer Says

  August 14, 2013

   · 

  1 min read
• Drug Development

  Ultragenyx Pharmaceuticals Receives Approval of Clinical Trial Application (CTA) for a Phase 1/2 Trial Testing UX003 in Mucopolysaccharidosis Type 7 (MPS 7)

  August 14, 2013

   · 

  1 min read
• BioMidwest

  Capstone Therapeutics Will Provide an Operating Update and Announces Second Quarter 2013 Financial Results

  August 14, 2013

   · 

  3 min read
• Drug Development

  Immunomedics, Inc. Release: Epratuzumab and Rituximab Produce High Rate and Durable Progression-Free Survival in Previously Untreated Follicular Lymphoma

  August 14, 2013

   · 

  1 min read
• Policy

  Ingen Technologies, Inc. Settles $2.4M Judgment

  August 14, 2013

   · 

  1 min read
• Business

  Chimerix, Inc. Announces Second Quarter 2013 Financial Results

  August 14, 2013

   · 

  1 min read
• Business

  Genovis Evaluates New Technology for Early Diagnosis of Cardiovascular Disease

  August 14, 2013

   · 

  1 min read
• Pharm Country

  Cancer Genetics, Inc. Announces Pricing of Public Offering of 1,500,000 Shares of Common Stock

  August 14, 2013

   · 

  1 min read